Quantinuum's Nasdaq Debut at $14.3 Billion Valuation Sets Quantum Industry Benchmark

Quantinuum (QNT) is set to begin trading on Nasdaq after pricing a major IPO at $60 per share, raising about $1.68 billion and valuing the company at roughly $14–$15 billion. The company was formed in 2021 from a merger of Cambridge Quantum and Honeywell’s quantum unit, aiming to deliver full-stack quantum computing solutions spanning hardware and software for commercial, government, and research customers. Strong investor demand led Quantinuum to sell about 28 million shares and widen its terms, while Honeywell will retain a large voting stake, giving it substantial influence over the company’s direction. Analysts say the listing could improve price discovery and effectively set a benchmark for how investors value other, still-young publicly traded quantum firms. Retail traders and market commentary also frame the debut as a bullish industry signal amid expectations of continued government support, including a recently announced $2 billion U.S. quantum funding package tied to the current President Donald Trump administration, where Quantinuum is slated to receive $100 million.
Quantinuum was reportedly seeking an IPO valuation as high as $14.3 billion ahead of its Nasdaq debut, positioning the deal as a potential benchmark for how investors price other quantum IPOs.
Wedbush analysts said Quantinuum’s valuation and early trading could “set the tone” for listed quantum peers, noting a strong correlation among quantum stocks.
After the offering, Honeywell is set to retain about 48.1% of Quantinuum’s combined voting power, and founder Ilyas Khan is identified as the largest individual shareholder.
Retail and social traders framed the listing as a bullish “signal,” including a note that the IPO was oversubscribed by roughly 20 times shares offered and speculation that other quantum incumbents could benefit (e.g., IonQ, D-Wave, Rigetti).
The $2 billion U.S. quantum package mentioned alongside the IPO included a much larger award for IBM—$1 billion—while Quantinuum is slated to receive $100 million (the same Quantinuum allocation also cited in broader coverage).
Publishers
23
Articles
19
Reach
42